PolyPid Ltd. (PYPD) News
Track canonical SquawkNews coverage tagged to PYPD, PolyPid Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
PYPD Reports Second Quarter 2026 Financial Results
PYPD reports second quarter 2026 financial results and provides corporate update
EARNINGS | Aug 12, 2026, 11:30 AM UTC
L
PYPD - PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
PYPD - PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
EARNINGS | Jul 30, 2026, 12:00 PM UTC
L
PYPD Polypid announces FDA Acceptance of NDA with priority review for D-plex₁₀₀ Polypid - FDA sets pdufa target action date of November 28,
PYPD Polypid announces FDA Acceptance of NDA with priority review for D-plex₁₀₀ Polypid - FDA sets pdufa target action date of November 28, 2026 for D-plex100 - FDA Acceptance triggers $15M milestone payment, completing
REGULATION | Jul 29, 2026, 12:30 PM UTC
L
PYPD Polypid announces exclusive partnership with azurity Pharmaceuticals for the commercialization of D-plex₁₀₀ in the U.S. and Canada Poly
PYPD Polypid announces exclusive partnership with azurity Pharmaceuticals for the commercialization of D-plex₁₀₀ in the U.S. and Canada Polypid - to receive over $320M in payments plus tiered royalties - To receive $15M
REGULATION | Jul 21, 2026, 11:30 AM UTC